Diabetic Retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels in the light-sensitive tissue at the back of the eye (retina). The condition can progressively worsen and potentially lead to blindness. Treatment options include: Focal/Grid Laser Photocoagulation, Intravitreal Injections (Anti-VEGF agents or Corticosteroids), and Vitrectomy. These interventions aim to reduce the risk of vision loss and improve overall visual function.
Diabetic Retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels in the light-sensitive tissue at the back of the eye (retina). The condition can progressively worsen and potentially lead to blindness. Treatment options include: Focal/Grid Laser Photocoagulation, Intravitreal Injections (Anti-VEGF agents or Corticosteroids), and Vitrectomy. These interventions aim to reduce the risk of vision loss and improve overall visual function.
Diabetic Retinopathy is treated through injections of anti-vascular endothelial growth factor (Avastin or Lucentis) or laser photocoagulation to prevent vision loss. Mexico offers these treatments at a lower cost than the US.
Mexico's medical tourism industry attracts many patients due to affordable prices and high-quality care. Diabetic Retinopathy treatment waiting times can range from 1 to 3 weeks.